|Articles|February 1, 2012
- Applied Clinical Trials-02-01-2012
- Volume 21
- Issue 2
Applied Clinical Trials Digital Edition - February 2012
TRIAL DESIGN : Enrollment is More Than a Numbers Game REGULATORY : Late Phase PK Collection Also in this issue : Protocol Design and Study Management, Effects of Europe?s Economic Turbulence, Ready for Big Data?, Outcomes Assessments
Advertisement
Articles in this issue
almost 14 years ago
Unexpected Trend in Global Subject Enrollmentalmost 14 years ago
Increasing the Use of Technology in Feasibilityalmost 14 years ago
Pharmacovigilance Alliancesalmost 14 years ago
PPD Trains CRAs in Three Dimensionsalmost 14 years ago
Business and News Update February 2012almost 14 years ago
Looking Beyond the Euro Turmoilalmost 14 years ago
Give the Patient a Clear Voicealmost 14 years ago
Quality Approaches Key to Transforming Researchalmost 14 years ago
Strategic Partnershipalmost 14 years ago
Leveraging the TransitionNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
